{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:01:53Z","timestamp":1791352913768,"version":"4.3.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jns-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.jns.2017.01.014","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T07:21:22Z","timestamp":1483687282000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Hallucinations and the spectrum of psychosis in Parkinson's disease"],"prefix":"10.1016","volume":"374","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5257-2997","authenticated-orcid":false,"given":"Karen","family":"Frei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Truong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.jns.2017.01.014_bb0005","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s40265-016-0600-5","article-title":"Psychosis in Parkinson's disease: epidemiology, pathophysiology and management","volume":"76","author":"Chang","year":"2016","journal-title":"Drugs"},{"issue":"8","key":"10.1016\/j.jns.2017.01.014_bb0010","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/mds.21382","article-title":"Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group","volume":"22","author":"Ravina","year":"2007","journal-title":"Mov. Disord."},{"issue":"1","key":"10.1016\/j.jns.2017.01.014_bb0015","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26432","article-title":"Minor hallucinations occur in drug-na\u00efve Parkinson's disease patients, even from the premotor phase","volume":"31","author":"Pagonabarra","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.01.014_bb0020","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson's disease. Prevalence, phenomenology and risk factors","volume":"123","author":"Fenelon","year":"2000","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jns.2017.01.014_bb0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mds.22839","article-title":"The changing face of Parkinson's disease associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria","volume":"25","author":"Fenelon","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.01.014_bb0030","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jnnp.2007.124677","article-title":"Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical parkinsonism","volume":"79","author":"Williams","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.jns.2017.01.014_bb0035","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/mds.20582","article-title":"Relationship between hallucinations, delusions and rapid eye movement sleep behavior disorder in Parkinson's disease","volume":"20","author":"Pacchetti","year":"2005","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.01.014_bb0040","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","article-title":"Epidemiology of psychosis in Parkinson's disease","volume":"289","author":"Fenelon","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.01.014_bb0045","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.wnf.0000180228.77802.32","article-title":"Drug-induced psychosis in Parkinson disease. Phenomenology and correlations among psychosis rating instruments","author":"Chou","year":"2005","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.jns.2017.01.014_bb0050","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/jnnp.2010.234799","article-title":"Feeling of presence in Parkinson's disease","volume":"82","author":"Fenelon","year":"2011","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.01.014_bb0055","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.parkreldis.2013.11.017","article-title":"Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease","volume":"20","author":"Pagonabarraga","year":"2014","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.jns.2017.01.014_bb0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","article-title":"Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study","volume":"4","author":"Williams","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2017.01.014_bb0065","series-title":"Hallucinations","author":"Sacks","year":"2012"},{"issue":"2","key":"10.1016\/j.jns.2017.01.014_bb0070","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/JGP.0b013e31821f1b41","article-title":"Prevalence of psychotic symptoms in a community-based Parkinson disease sample","volume":"20","author":"Mack","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jns.2017.01.014_bb0075","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13760-012-0027-z","article-title":"Hallucinations in Parkinson's disease: cross-sectional study","volume":"112","author":"Svetel","year":"2012","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.jns.2017.01.014_bb0080","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s004150050104","article-title":"A study of visual hallucinations in patients with Parkinson's disease","volume":"244","author":"Klein","year":"1997","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.01.014_bb0085","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1136\/jnnp.70.6.734","article-title":"Prospective study of hallucinations and delusions in Parkinson's disease","volume":"70","author":"Holroyd","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.01.014_bb0090","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/archneur.1996.00550120077019","article-title":"Visual hallucinations associated with Parkinson disease","volume":"53","author":"Sanchez-Ramos","year":"1996","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2017.01.014_bb0095","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/mds.23004","article-title":"Background scenery visual hallucinations in a depressed patient with Parkinson's disease","volume":"25","author":"Inoue","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.01.014_bb0100","first-page":"2013","article-title":"Visual hallucinations in photographs in Parkinson's disease","volume":"22","author":"Vaou","year":"2013","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.jns.2017.01.014_bb0105","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/121.10.1819","article-title":"Complex visual hallucinations. Clinical and neurobiological insights","volume":"121","author":"Manford","year":"1998","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.jns.2017.01.014_bb0110","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1176\/ajp.135.6.669","article-title":"Levodopa-induced psychosis: a kindling phenomenon","volume":"135","author":"Moskovitz","year":"1978","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jns.2017.01.014_bb0115","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/brain\/awf033","article-title":"Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe","volume":"125","author":"Harding","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.01.014_bb0120","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1007\/s100720200085","article-title":"Incidence of RBD and hallucinations in patients affected by Parkinson's disease: 8-year follow-up","volume":"23","author":"Onofrj","year":"2002","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2017.01.014_bb0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/jnnp.64.4.533","article-title":"Auditory hallucinations in Parkinson's disease","volume":"64","author":"Inzelberg","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.01.014_bb0130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.wnf.0000144040.20600.c1","article-title":"Threatening auditory hallucinations and Cotard syndrome in Parkinson's disease","volume":"27","author":"Factor","year":"2004","journal-title":"Clin. Neuropharmacol."},{"issue":"7","key":"10.1016\/j.jns.2017.01.014_bb0135","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1017\/S1041610212002037","article-title":"A case in which mirtazapine reduced auditory hallucinations in a patient with Parkinson's disease","volume":"25","author":"Nagata","year":"2013","journal-title":"Int. Psychogeriatr."},{"issue":"8","key":"10.1016\/j.jns.2017.01.014_bb0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/SMJ.0b013e3181e63204","article-title":"Elvis is back: musical hallucinations in a Parkinson's disease patient","volume":"103","author":"Mittal","year":"2010","journal-title":"South. Med. J."},{"key":"10.1016\/j.jns.2017.01.014_bb0145","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/NRL.0b013e3181872da7","article-title":"Musical hallucinations and Parkinson's disease","volume":"15","author":"Ergun","year":"2009","journal-title":"Neurologist"},{"key":"10.1016\/j.jns.2017.01.014_bb0150","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/(SICI)1099-1166(1998120)13:12<886::AID-GPS883>3.0.CO;2-G","article-title":"Case history of a patient with musical hallucinations and Parkinson's disease","volume":"13","author":"Clark","year":"1998","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"10","key":"10.1016\/j.jns.2017.01.014_bb0155","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/mds.22553","article-title":"Transient amantadine-induced musical hallucinations in a patient with Parkinson's disease","volume":"25","author":"Gondim","year":"2010","journal-title":"Mov. Disord."},{"issue":"27","key":"10.1016\/j.jns.2017.01.014_bb0160","doi-asserted-by":"crossref","first-page":"e 251","DOI":"10.1097\/MD.0000000000000251","article-title":"Auditory musical hallucinations associated with extended release pramipexole in an elderly patient with Parkinson's disease","volume":"93","author":"Kataoka","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.jns.2017.01.014_bb0165","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/0004867411433221","article-title":"Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression","volume":"46","author":"Wand","year":"2012","journal-title":"Aust NZ J. Psychiatry"},{"key":"10.1016\/j.jns.2017.01.014_bb0170","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/jnnp-2012-302414","article-title":"Prevalence and phenomenology of olfactory hallucinations in Parkinson's disease","volume":"83","author":"Bannier","year":"2012","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.jns.2017.01.014_bb0175","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archneur.65.9.1237","article-title":"Phantosmias and Parkinson disease","volume":"65","author":"Landis","year":"2008","journal-title":"Arch. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2017.01.014_bb0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archneurol.2009.87","article-title":"Olfactory disturbance in Parkinson's disease","volume":"66","author":"Singh","year":"2009","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2017.01.014_bb0185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3233\/JPD-2012-012086","article-title":"Prevalence and clinical course of olfactory hallucinations in idiopathic Parkinson's disease","volume":"2","author":"McAuley","year":"2012","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.jns.2017.01.014_bb0190","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.parkreldis.2004.01.003","article-title":"Olfactory and visual hallucinations in Parkinson's disease","volume":"10","author":"Tousi","year":"2004","journal-title":"Parkinsonism Relat. Disord."},{"issue":"12","key":"10.1016\/j.jns.2017.01.014_bb0195","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00415-002-0908-9","article-title":"Tactile hallucinations in Parkinson's disease","volume":"249","author":"Fenelon","year":"2002","journal-title":"J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.jns.2017.01.014_bb0200","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jns.2014.10.014","article-title":"Can dopamine agonists trigger tactile hallucinations in patients with Parkinson's disease?","volume":"347","author":"Kataoka","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2017.01.014_bb0205","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/jnnp.63.1.120","article-title":"Cenesthetic hallucinations in a patient with Parkinson's disease","volume":"63","author":"Jimenez-Jimenez","year":"1997","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2017.01.014_bb0210","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00415-006-0388-4","article-title":"Relationship between age and subtypes of psychotic symptoms in Parkinson's disease","volume":"254","author":"Kiziltan","year":"2007","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2017.01.014_bb0215","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/NRL.0000000000000010","article-title":"Fluctuating Cotard syndrome in a patient with advanced Parkinson disease","volume":"19","author":"Solla","year":"2015","journal-title":"Neurologist"},{"key":"10.1016\/j.jns.2017.01.014_bb0220","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.parkreldis.2013.04.021","article-title":"Delusional misidentification syndrome and other unusual delusions in advanced Parkinson's disease","volume":"19","author":"Moro","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.1016\/j.jns.2017.01.014_bb0225","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/NRL.0b013e3181883dd4","article-title":"Othello syndrome in Parkinson disease patients without dementia","volume":"15","author":"Cannas","year":"2009","journal-title":"Neurologist"},{"key":"10.1016\/j.jns.2017.01.014_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/089198879100400306","article-title":"Reversible pathologic jealousy (Othello syndrome) associated with amantadine","volume":"4","author":"McNamara","year":"1991","journal-title":"J. Geriatr. Psychiatry Neurol."},{"issue":"4","key":"10.1016\/j.jns.2017.01.014_bb0235","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1176\/jnp.14.4.462","article-title":"A blind man with Parkinson's disease, visual hallucinations and Capgras syndrome","volume":"14","author":"Hermanowicz","year":"2002","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jns.2017.01.014_bb0240","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1212\/01.WNL.0000129843.15756.A3","article-title":"Psychiatric comorbidities in patients with Parkinson disease and psychosis","volume":"63","author":"Marsh","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jns.2017.01.014_bb0245","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s004150170097","article-title":"Capgras syndrome in Parkinson's disease","volume":"248","author":"Miwa","year":"2001","journal-title":"J. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2017.01.014_bb0250","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1176\/appi.neuropsych.11010016","article-title":"Combined delusional misidentification syndrome in a patient with Parkinson's disease","volume":"24","author":"Cercy","year":"2012","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jns.2017.01.014_bb0255","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12888-015-0460-7","article-title":"Capgras delusion for animal and inanimate objects in Parkinson's disease: a case report","volume":"15","author":"Islam","year":"2015","journal-title":"BMC Psychiatry"},{"issue":"3","key":"10.1016\/j.jns.2017.01.014_bb0260","article-title":"Capgras syndrome during the course of Parkinson's disease dementia","volume":"26","author":"Apaydini","year":"2014","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jns.2017.01.014_bb0265","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/mds.21843","article-title":"Fregoli syndrome associated with levodopa treatment","volume":"23","author":"Stewart","year":"2008","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2017.01.014_bb0270","first-page":"27","article-title":"Capgras syndrome in a patient with Parkinson's disease after bilateral subthalamic nucleus deep brain stimulation: a case report","volume":"7","author":"Kyrtaos","year":"2015","journal-title":"Case Rep. Neurol."},{"key":"10.1016\/j.jns.2017.01.014_bb0275","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s100720170043","article-title":"Chronic delusional hallucinatory psychosis in early onset Parkinson's disease: drug-induced complication or sign of an idiopathic psychiatric illness?","volume":"22","author":"Cannas","year":"2001","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.jns.2017.01.014_bb0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2377-8-21","article-title":"A questionnaire-based (UM_PDHQ) study of hallucinations in Parkinson's disease","volume":"8","author":"Papapetropoulos","year":"2008","journal-title":"BMC Neurol."},{"key":"10.1016\/j.jns.2017.01.014_bb0285","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archneur.56.5.595","article-title":"Prevalence and clinical correlates of psychotic symptoms in Parkinson disease","volume":"56","author":"Aarsland","year":"1999","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2017.01.014_bb0290","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.jns.2017.01.014_bb0295","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1176\/appi.neuropsych.15050119","article-title":"Clinical implications of the National Institute of Neurological Disorders and Stroke criteria for diagnosing psychosis in Parkinson's disease","volume":"28","author":"Gordon","year":"2016","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.jns.2017.01.014_bb0300","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1212\/WNL.57.11.2078","article-title":"Hallucinations and sleep disorders in Parkinson's disease: ten-year prospective longitudinal study","volume":"57","author":"Goetz","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.01.014_bb0305","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/archneur.63.5.713","article-title":"The malignant course of \u201cbenign hallucinations\u201d in Parkinson disease","volume":"63","author":"Goetz","year":"2006","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2017.01.014_bb0310","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1002\/mds.23835","article-title":"Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10years","volume":"26","author":"Goetz","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.01.014_bb0315","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/mds.20701","article-title":"Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patient","volume":"21","author":"Goetz","year":"2006","journal-title":"Mov. Disord."},{"issue":"2","key":"10.1016\/j.jns.2017.01.014_bb0320","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mds.20263","article-title":"Hallucinations in Parkinson's disease: a follow-up study","volume":"20","author":"De Maindreville","year":"2005","journal-title":"Mov. Disord."},{"issue":"8","key":"10.1016\/j.jns.2017.01.014_bb0325","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneurol.2010.166","article-title":"A 12-year population-based study of psychosis in Parkinson's disease","volume":"67","author":"Forsaa","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2017.01.014_bb0330","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/gps.3869","article-title":"Frequency, prevalence, incidence and risk factors associated with visual hallucinations in a sample of patients with Parkinson's disease: a longitudinal 4-year study","volume":"28","author":"Gibson","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jns.2017.01.014_bb0335","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.parkreldis.2008.11.013","article-title":"Non-motor symptoms in a prevalent population with Parkinson's disease in Tanzania","volume":"15","author":"Dotchin","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"issue":"2","key":"10.1016\/j.jns.2017.01.014_bb0340","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1212\/WNL.50.2.515","article-title":"Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations","volume":"50","author":"Goetz","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.01.014_bb0345","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1212\/01.wnl.0000191325.31068.c4","article-title":"Hallucinations in Parkinson's disease in the prelevodopa era","volume":"66","author":"Fenelon","year":"2006","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.jns.2017.01.014_bb0350","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/mds.22132","article-title":"Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: positive impact on long-term worsening","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2017.01.014_bb0355","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11920-016-0730-1","article-title":"The current understanding of psychosis in Parkinson's disease","volume":"18","author":"Ojo","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"issue":"2","key":"10.1016\/j.jns.2017.01.014_bb0360","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/00002826-200403000-00009","article-title":"Antidepressants in the treatment of psychosis with comorbid depression in Parkinson's disease","volume":"27","author":"Voon","year":"2004","journal-title":"Clin. Neuropharmacol."},{"issue":"2","key":"10.1016\/j.jns.2017.01.014_bb0365","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1479-8301.2012.00432.x","article-title":"Mirtazapine improves visual hallucinations in Parkinson's disease: a case report","volume":"13","author":"Tagai","year":"2013","journal-title":"Psychogeriatrics"},{"issue":"03","key":"10.1016\/j.jns.2017.01.014_bb0370","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1055\/s-0034-1367014","article-title":"Reduction of parkinsonism and psychosis with mirtazapine: a case report","volume":"47","author":"Godschalk-Dekker","year":"2014","journal-title":"Pharmacopsychiatry"},{"issue":"11","key":"10.1016\/j.jns.2017.01.014_bb0375","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s00702-014-1212-4","article-title":"Quantitative evaluation of electroconvulsive therapy for Parkinson's disease with refractory psychiatric symptoms","volume":"121","author":"Nishioka","year":"2014","journal-title":"J. Neural Transm. (Viena)"},{"key":"10.1016\/j.jns.2017.01.014_bb0380","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jagp.2016.08.017","article-title":"Neuropsychiatric complications of Parkinson disease treatments: importance of multidisciplinary care","volume":"24","author":"Taylor","year":"2016","journal-title":"Am. J. Geriatr. Psychiatry"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17300138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X17300138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T21:21:24Z","timestamp":1658352084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X17300138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":76,"alternative-id":["S0022510X17300138"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.01.014","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hallucinations and the spectrum of psychosis in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}